We are live on ! Find out more
CCM

Coldstream Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 17.95%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+17.95%
3 Year Est. Return
+59.03%
5 Year Est. Return
10 Year Est. Return
AUM
$3.19B
AUM Growth
+$1.12B
Cap. Flow
+$534M
Cap. Flow %
16.76%
Top 10 Hldgs %
44.61%
Holding
864
New
460
Increased
274
Reduced
95
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 16%
2 Consumer Discretionary 6.59%
3 Financials 4.56%
4 Healthcare 3.66%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFO
376
DELISTED
IHS Markit Ltd. Common Shares
INFO
$571K 0.02%
+4,295
New +$547K
SO icon
377
Southern Company
SO
$106B
$570K 0.02%
+8,306
New +$530K
PGR icon
378
Progressive
PGR
$124B
$569K 0.02%
5,548
+2,867
+107% +$274K
MSCI icon
379
MSCI
MSCI
$41.9B
$567K 0.02%
+925
New +$580K
SLAB icon
380
Silicon Laboratories
SLAB
$7.15B
$567K 0.02%
+2,744
New +$505K
ALC icon
381
Alcon
ALC
$33.9B
$565K 0.02%
6,484
-1,806
-22% -$149K
RDFN
382
DELISTED
Redfin
RDFN
$565K 0.02%
14,712
+8,835
+150% +$401K
VRTX icon
383
Vertex Pharmaceuticals
VRTX
$122B
$564K 0.02%
2,569
+1,212
+89% +$236K
A icon
384
Agilent Technologies
A
$39.2B
$563K 0.02%
3,529
-8,919
-72% -$1.39M
LULU icon
385
lululemon athletica
LULU
$13.6B
$563K 0.02%
1,439
-356
-20% -$152K
SPMD icon
386
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
$562K 0.02%
+11,297
New +$552K
REGN icon
387
Regeneron Pharmaceuticals
REGN
$77.4B
$560K 0.02%
887
+475
+115% +$292K
ENPH icon
388
Enphase Energy
ENPH
$4.94B
$559K 0.02%
+3,058
New +$638K
CB icon
389
Chubb
CB
$135B
$557K 0.02%
+2,879
New +$541K
GIS icon
390
General Mills
GIS
$19.4B
$556K 0.02%
8,245
+3,334
+68% +$212K
ROP icon
391
Roper Technologies
ROP
$38.5B
$555K 0.02%
1,127
+520
+86% +$248K
SNPS icon
392
Synopsys
SNPS
$71.3B
$555K 0.02%
+1,507
New +$508K
PMF
393
DELISTED
PIMCO Municipal Income Fund
PMF
$554K 0.02%
+36,395
New +$529K
DAR icon
394
Darling Ingredients
DAR
$9.69B
$553K 0.02%
+7,975
New +$580K
SYY icon
395
Sysco
SYY
$40.6B
$553K 0.02%
7,034
+2,644
+60% +$203K
CTLT
396
DELISTED
CATALENT, INC.
CTLT
$550K 0.02%
4,298
+1,201
+39% +$154K
CME icon
397
CME Group
CME
$96.1B
$549K 0.02%
+2,403
New +$529K
VBK icon
398
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
$548K 0.02%
+1,944
New +$557K
PXD
399
DELISTED
Pioneer Natural Resource Co.
PXD
$547K 0.02%
+3,010
New +$554K
IDXX icon
400
Idexx Laboratories
IDXX
$44.1B
$546K 0.02%
+829
New +$520K

Similar funds

Coldstream Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Coldstream Capital Management held 864 positions worth $3.19B, up 54% from $2.06B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Coldstream Capital Management deployed $534M of net new capital in Q4 2021, opening 460 new positions and adding to 274 existing holdings. Its largest new stake was First Trust Global Tactical Commodity Strategy Fund: 519,347 shares worth $12M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $29.7M trimmed.

  • Coldstream Capital Management's largest Q4 2021 buy was First Trust Global Tactical Commodity Strategy Fund: 519,347 shares worth $12M.
  • Coldstream Capital Management added most to iShares Currency Hedged MSCI EAFE ETF in Q4 2021, an estimated $67.5M increase.
  • Coldstream Capital Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $29.7M.
  • Coldstream Capital Management fully exited Slack Technologies, Inc. in Q4 2021, selling an estimated $5.95M.
  • Coldstream Capital Management's ten largest holdings make up 45% of its $3.19B portfolio in Q4 2021.
  • Coldstream Capital Management opened 460 new positions and closed 25 in Q4 2021.
  • Coldstream Capital Management's portfolio value rose 54% quarter-over-quarter to $3.19B.

Based on Coldstream Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.